Andrew Murphy - Dec 6, 2024 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
EVP Research
Signature
/s/ Andrew Murphy
Stock symbol
REGN
Transactions as of
Dec 6, 2024
Transactions value $
-$387,204
Form type
4
Date filed
12/10/2024, 04:03 PM
Previous filing
Nov 12, 2024
Next filing
Dec 18, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Award $0 +3.5K +7.43% $0.00 50.6K Dec 6, 2024 Direct F1
transaction REGN Common Stock Tax liability -$387K -492 -0.97% $787.00 50.1K Dec 9, 2024 Direct
holding REGN Common Stock 4.33K Dec 6, 2024 By 401(k) Plan

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction REGN Non-Qualified Stock Option (right to buy) Award $0 +13.5K $0.00 13.5K Dec 6, 2024 Common Stock 13.5K $771.64 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Award of Restricted Stock under the Second Amended and Restated 2014 Long-Term Incentive Plan that vests 50% on December 6, 2026 and 50% on December 6, 2028.
F2 The stock option award vests in four equal annual installments, commencing one year after the date of grant.